Awaiting Developments from the Lab
Stay tuned to KBLB for new info coming out of the lab. We like what we hear and are waiting for full details. Should be exciting to hear about the results of the increasing number of micoinjections. Joe Noel
Update - Success in the Lab!
The announcement Kraig made early last week was highly significant. The release used quite a few terms that probably confuse the vast majority of small-cap investors - after all, we are not genetic scientists are we? Let me take a moment to explain what was announced and why it’s important.
The researchers have been working to inject the specific spider DNA that is responsible for silk production into silkworms so that the silkworms produce spider silk. They have replicated this DNA and combined it with DNA that causes fluorescence. The combined DNA creates somewhat of a “suitcase” of DNA, which contains both types of DNA - spider silk DNA and the DNA that causes fluorescence. This “suitcase” of DNA is then injected into silkworms eggs. Oftentimes the DNA within the “suitcase” will not make its way into the DNA of the silkworm, but sometimes it does. Using this method it’s easy to determine if the new DNA makes it into the silkworm because if it does the silkworm will glow with florescence.
Over the past couple months the research team had significantly increased the number of attempts to insert these DNA “suitcases” into silkworm eggs. A couple of weeks ago, they achieved success, noticing the offspring were glowing. This means that the silkworms are in fact transgenic and that the inserted DNA was taken up by the insects - effectively, creating a new life form. This was a significant achievement.
The next step will be to determine if the new transgenic silkworms are germline stable – meaning, will they pass the new DNA to the next generation. If it is passed to the next generation the next step will be to test the resulting silk produced by the silkworms to determine its properties. This is a process that only takes a couple of weeks, so depending on the outcome we could have major news pending.
Stay tuned here - we will keep you updated as developments occur.
Kraig Biocraft Labs (KBLB) Analyst Blog
Thank you for accessing the analyst blog for Kraig Biocraft Laboratories (KBLB). We have been covering this company since June of 2008. We are eagerly awaiting news of the latest developments occurring in the Notre Dame lab!
This company has some of the most brilliant genetic engineering scientists in the world working on creating transgenic silkworms that produce spider silk. The number of staff in the lab who are working on microinjections has recently been significantly increased and they have also modified the technique. What has resulted is a sharp increase in the number of microinjections taking place. In our opinion, we are likely to see a significant development over the near-term.
This is revolutionary technology that’s being created. The market for commercial spider silk could be worth billions of dollars and it is KBLB that is most likely to bring it to market. While the scientists will become famous for their accomplishments, it is the shareholders of KBLB, that will likely be the biggest winners. Should this company accomplish its goal, we believe the shares are worth well more than $4.00.
Stay tuned to this blog as we will be posting updates as they occur. Thanks for your interest. Our online research report can be viewed at http://www.wallstreetreportonline.com/KBLB/index.htm
Feel free to send us an email at jnoel701@yahoo.com if you have any questions on the company. We would really like to hear your thoughts.